Liver Disease

ASTRO Offers Guidance on EBRT for Primary Liver Cancers

February 14th 2022, 1:00pm


Contributor: Empowering Endocrinologists With Technology for the Diagnosis, Management, and Treatment of NAFLD

January 23rd 2022, 2:00pm


In this column, an endocrinologist discusses the growing problem of liver disease and new options at their disposal, including vibration-controlled transient elastography.

Top 5 Most-Read Liver Disease Articles of 2021

December 28th 2021, 1:15pm


Chronic liver disease is on the rise and the burden is expected to increase in the future, both in the United States and around the world. These are the most-read articles about liver disease in 2021.

Posters Review Surveillance of Patients With NAFLD to Identify HCC

December 22nd 2021, 3:45pm


Two posters presented at The Liver Meeting evaluated nonalcoholic fatty liver disease (NAFLD)–associated hepatocellular carcinoma (HCC) to understand the burden and identify the risk for developing HCC.

Study Finds First-Degree Family History of Diabetes Linked With NAFLD

December 19th 2021, 12:45am


Using the fatty liver index (FLI) to identify nonalcoholic fatty liver disease (NAFLD), researchers sought to understand the association between first-degree family members of patients with diabetes and NAFLD.

Educational Interventions Are Needed to Address Knowledge Gaps for Management of NASH

December 13th 2021, 4:30pm


Two posters presented at The Liver Meeting identified the primary care coordinators for patients with nonalcoholic steatohepatitis (NASH) and areas of unmet need among specialists to provide optimal management.

Evaluating Factors Impacting Health Disparities in Liver Transplant

December 11th 2021, 7:30pm


Posters review how a patient’s neighborhood impacts access to the liver transplant waitlist and how Medicaid expansion improved waitlist mortality.

Dedicated Intervention Can Achieve Weight Loss in Patients With NALFD

December 10th 2021, 9:50pm


Guidelines recommend patients with nonalcoholic fatty liver disease (NAFLD) who are obese achieve 5% to 10% weight loss to prevent NAFLD progression.

Patients With NAFLD Have Higher Risk of HF, Study Finds

December 4th 2021, 8:30pm


Specifically, patients with nonalcoholic fatty liver disease (NAFLD) have a higher risk of developing heart failure (HF) with preserved ejection fraction, according to new research.

Healthy Eating, Exercise Encouraged to Help Improve QOL in NAFLD

December 3rd 2021, 9:30pm


Authors of a review published in Hormones outlined the benefits of healthy eating and physical activity to prevent and improve non-alcoholic fatty liver disease.